Skip to main content

Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform

Major Release to Help Life Science Companies Maximize Go-to-Market Impact Princeton, N.J., July 8, 2021. Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies … Continued

Using BaseCase to communicate product value in decentralized accounts

Securing market access in decentralized accounts was proving difficult for our client. Recognizing the need for more localized messaging, they hired an agency to transform their economic models and presentations into interactive apps. However, long timeframes and significant extra costs meant this wasn’t feasible long-term. They then turned to BaseCase, allowing them to develop such apps … Continued

Diagnostics and Devices: Accelerating Value Communication With Interactive Messaging

Learn how to accelerate decision-makers’ understanding of the value of diagnostic testing and medical devices to the health system. Two industry experts with over 35 years’ combined experience, Atlanta Kassatly, VP of Consulting at Certara, and Cynthia Doucet, President of OutcomeSynergy, discussed recent trends and issues that can hinder successful communication. Real-world solutions were reviewed … Continued

1 of 1